BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27467226)

  • 1. Metastatic Cutaneous Squamous Cell Carcinoma: The Importance of T2 Stratification and Hematologic Malignancy in Prognostication.
    Stevenson ML; Kim R; Meehan SA; Pavlick AC; Carucci JA
    Dermatol Surg; 2016 Aug; 42(8):932-5. PubMed ID: 27467226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
    Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
    Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
    Blechman AB; Carucci JA; Stevenson ML
    Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
    Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
    JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
    Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
    JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.
    Inda JJ; Kabat BF; Larson MC; Slager SL; Baum CL
    J Am Acad Dermatol; 2019 Mar; 80(3):639-645. PubMed ID: 30165169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
    Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
    J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
    Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
    J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma.
    Upton M; Kita A; Scapa J; St John M
    Laryngoscope; 2021 Jan; 131(1):E170-E175. PubMed ID: 32212346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
    Ruiz ES; Karia PS; Besaw R; Schmults CD
    JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
    Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
    Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Value of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Based on the AJCC-8 and Brigham and Women's Hospital Staging Criteria.
    Tejera-Vaquerizo A; Cañueto J; Llombart B; Martorell-Calatayud A; Sanmartín O
    Dermatol Surg; 2020 Jul; 46(7):857-862. PubMed ID: 31567487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis and Comparison of the 8th Edition American Joint Committee on Cancer (AJCC) Nodal Staging System in Cutaneous and Oral Squamous Cell Cancer of the Head and Neck.
    Moeckelmann N; Ebrahimi A; Dirven R; Liu J; Low TH; Gupta R; Ashford B; Ch'ng S; Palme CE; Clark JR
    Ann Surg Oncol; 2018 Jun; 25(6):1730-1736. PubMed ID: 29352431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system.
    Schmitt AR; Brewer JD; Bordeaux JS; Baum CL
    JAMA Dermatol; 2014 Jan; 150(1):19-24. PubMed ID: 24226651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
    Que SKT; Zwald FO; Schmults CD
    J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
    Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
    J Am Acad Dermatol; 2021 Sep; 85(3):582-587. PubMed ID: 33497751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis and comparison of the 7th edition American Joint Committee on Cancer (AJCC) nodal staging system for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Clark JR; Rumcheva P; Veness MJ
    Ann Surg Oncol; 2012 Dec; 19(13):4252-8. PubMed ID: 22805870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
    Burton KA; Ashack KA; Khachemoune A
    Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.
    Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA
    JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case-Control Study of Tumor Stage-Dependent Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed and Immunocompetent Patients.
    Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
    Dermatol Surg; 2019 Dec; 45(12):1467-1476. PubMed ID: 30964787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.